Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study

BACKGROUND: Ten-valent pneumococcal conjugate vaccine (PCV10), delivered at 6, 10, and 14 weeks of age was introduced in Kenya in January, 2011, accompanied by a catch-up campaign in Kilifi County for children aged younger than 5 years. Coverage with at least two PCV10 doses in children aged 2–11 mo...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Lancet
Hlavní autoři: Hammitt, Laura L, Etyang, Anthony O, Morpeth, Susan C, Ojal, John, Mutuku, Alex, Mturi, Neema, Moisi, Jennifer C, Adetifa, Ifedayo M, Karani, Angela, Akech, Donald O, Otiende, Mark, Bwanaali, Tahreni, Wafula, Jackline, Mataza, Christine, Mumbo, Edward, Tabu, Collins, Knoll, Maria Deloria, Bauni, Evasius, Marsh, Kevin, Williams, Thomas N, Kamau, Tatu, Sharif, Shahnaaz K, Levine, Orin S, Scott, J Anthony G
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6548991/
https://ncbi.nlm.nih.gov/pubmed/31000194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(18)33005-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky